We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Researchers Define the Structure of Parkinson's Disease Protein Aggregates

By LabMedica International staff writers
Posted on 12 Apr 2016
Print article
The use of advanced imaging techniques has enabled biochemists to determine the molecular structure of alpha-synuclein protein fibrils such as those found in the brains of individuals with Parkinson's disease.

The accumulation of misfolded alpha-synuclein amyloid fibrils leads to the formation of insoluble aggregates that have been implicated in several neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. It has been exceedingly difficult to define the structure of alpha-synuclein fibrils due to their insolubility and complexity.

Investigators at the University of Illinois (Champaign-Urbana, USA) and their collaborators used advanced imaging techniques such as magic-angle spinning nuclear magnetic resonance (a type of solid state NMR) to measure the placement of atoms in samples of alpha-synuclein.

They described in the March 28, 2016, online edition of the journal Nature Structural and Molecular Biology a structure with common amyloid features including parallel, in-register beta-sheets and hydrophobic-core residues. The structure revealed substantial complexity arising from diverse structural features including an intermolecular salt bridge, a glutamine ladder, close backbone interactions involving small residues, and several steric zippers stabilizing a new orthogonal Greek-key topology. The results were validated using EM (electron microscope) and X-ray fiber diffraction.

The investigators synthesized alpha-synuclein fibrils according to their structural data and showed that these fibrils induced robust Parkinson's-like pathology in primary neuronal cultures.

"We had to find patterns in the data and systematically test all the possibilities for how the protein would fit together," said senior author Dr. Chad Rienstra, professor of chemistry at the University of Illinois. "It is like when you solve a really complex puzzle, you know you have it right at the end because all the pieces fit together. That is what we got with this structure. This is the first structure of the full-length fibril protein, which is now well established to be important for the pathology of Parkinson's disease. Knowing that structure will open up many new areas of investigation for diagnosing and treating Parkinson's disease."

"We think that the structure that we resolved of alpha-synuclein fibrils will be really significant in the immediate future and has use for diagnosing Parkinson's in patients before they are symptomatic," said Dr. Rienstra. "Once people start having symptoms, whether of Alzheimer's or Parkinson's, in many ways it is a little too late to be effective with therapy. But if you catch it early, I think there is a lot of promise for therapies that are being developed. Those are all relying upon the structures that we are solving."

Related Links:

University of Illinois


Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
New
Auto Immunochemistry System
AFIAS-10
New
Platinum Supplier
Ultra-Low PSA Control
Prostate-Specific Antigen Control

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more

Microbiology

view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more

Pathology

view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

Hemoglobin A1c (HbA1c), or glycated hemoglobin, refers to hemoglobin with glucose attached. HbA1c testing devices are used for blood tests that determine average blood glucose, or blood sugar levels.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.